ADJUVANCE TECHNOLOGIES INC
formerly Adjuvance TechnologiesLincoln, United States · Founded 2017 · $23.0M raised
- Headquarters
- Lincoln, Nebraska
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- adjuvancetechnologies.org
- Total Funding
- $23.0M
- Last Round
- $1.5M GrantMay 2020
- Rounds
- 6
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 6 funding rounds and 4 investors for this company. The full record is or through the API.
About
Adjuvance Technologies is a Lincoln, Nebraska biopharmaceutical company developing next-generation semi-synthetic saponin adjuvants to improve vaccine efficacy and duration. The company licenses its proprietary adjuvant platform to vaccine developers globally and has collaborated with Memorial Sloan-Kettering Cancer Center.
Summary
ADJUVANCE TECHNOLOGIES INC is a Biotech company based in Lincoln, United States, founded in 2017. It has raised $23.0M in total across 6 rounds, most recently a $1.5M Grant round in May 2020. Investors include National Institutes of Health, Morningside Group and 5Y Capital.
Funding History
May 2020
Sign up to see all 6 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/adjuvance-technologies-inc"><img src="https://indexed.vc/api/badge/company/adjuvance-technologies-inc" alt="ADJUVANCE TECHNOLOGIES INC on Indexed.vc" width="260" height="76" /></a>